STOCK TITAN

Meridian Corporation Form 4 Filings

MRBK NASDAQ

Every Form 4 that Meridian Corporation (MRBK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MRBK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MRBK filings page.

Rhea-AI Summary

Meridian Corp director Kenneth Thomas Warriner reported two recent stock acquisitions. On the most recent date, he received a grant of 50 shares of common stock valued at $19.96 per share as restricted stock that will vest in full on the one-year anniversary of the grant.

Earlier, he made an open-market purchase of 1,000 shares of common stock at $18.00 per share. Following these transactions, he directly holds 3,050 shares of Meridian Corp common stock. The filing combines a compensation-related award with a personal share purchase.

Rhea-AI Summary

Meridian Corp Chairman & CEO Christopher J. Annas reported an option-related share exercise and tax withholding. On June 8, 2026, he exercised 42,000 employee stock options at $7.62 per share, converting them into common stock. To satisfy the exercise price, 16,642 common shares were withheld by the company at a value of $19.23 per share, rather than sold on the open market. After these transactions, he directly holds 393,865 shares of Meridian Corp common stock.

Rhea-AI Summary

Meridian Corp director Anthony Mark Imbesi reported an open-market purchase of company stock. He bought 1,000 shares of common stock at a price of $17.381 per share, increasing his direct ownership to 386,156 shares following the transaction.

Rhea-AI Summary

Meridian Corp director Robert T. Holland exercised stock options to acquire 10,500 shares of COMMON STOCK on May 7, 2026 at an exercise price of $7.62 per share. Following the transaction, he directly owns 88,052.323 shares of Meridian common stock. The derivative entry shows the corresponding stock options for 10,500 shares were fully exercised, leaving no remaining options from this grant before their stated expiration on June 15, 2026.

Rhea-AI Summary

Meridian Corp director Kenneth Thomas Warriner reported an open-market purchase of common stock. He bought 1,000 shares of Meridian Corp common stock at $18.415 per share, increasing his direct holdings to 2,000 shares of common stock following the transaction.

Rhea-AI Summary

Meridian Corp director Edward J. Hollin exercised stock options to acquire 600 shares of common stock on 2026-04-29. These transactions increase his direct equity exposure through option exercises rather than open-market purchases.

The options were exercised in three lots of 200 shares each at exercise prices of $13.00, $12.22 and $13.88 per share, reflecting previously granted awards that vest over time. No shares were sold in these transactions.

Rhea-AI Summary

Meridian Corp EVP Martindell Clarence Addis exercised employee stock options and increased his common stock holdings. On March 13, 2026, he exercised options for 4,000 shares of common stock at $9.50 per share, leaving him with 20,970 common shares held directly after the transaction.

Earlier, on November 17, 2025, he received a grant of 12,000 employee stock options with an exercise price of $14.43 and an expiration date of November 17, 2035. The options vest 25% on the grant date and then in three equal annual installments beginning on the one-year anniversary of each grant.

Rhea-AI Summary

Meridian Corp director Collier George C. III reported exercising stock options that converted into 1,600 shares of common stock on March 6, 2026, at exercise prices ranging from $6.74 to $15.50 per share.

Following these option exercises, he directly owns 67,636 shares of Meridian common stock. The filing shows only option exercises and no open‑market purchases or sales, indicating compensation-related equity being turned into common shares.

Rhea-AI Summary

Meridian Corp (MRBK) reported an insider equity award for one of its officers. The company’s Chief Credit Officer received an employee stock option grant for 3,500 shares of common stock on 11/17/2025 with an exercise price of $14.43 per share. These options are listed as directly owned.

The options become exercisable over time: they vest 25% on the grant date and then in three equal annual installments starting on the one-year anniversary of the grant date, continuing through 11/17/2035 as the stated expiration date. This filing is a routine Form 4 disclosure of an officer’s equity-based compensation.

Rhea-AI Summary

Meridian Corp (MRBK) reported that its EVP and Chief Financial Officer received an employee stock option grant. On 11/17/2025, the executive was granted options to purchase 20,000 shares of common stock at an exercise price of $14.43 per share. These options are exercisable until 11/17/2035.

The options vest 25% on the grant date, with the remaining portion vesting in three equal annual installments beginning on the one-year anniversary of the grant. After this grant, the filing shows 20,000 derivative securities beneficially owned directly by the reporting person.

Rhea-AI Summary

Meridian Corp (MRBK) reported an insider equity award on a Form 4 for its Chairman & CEO, who is also a director. On 11/17/2025, the executive received an employee stock option grant covering 40,000 shares of common stock with an exercise price of $14.43 per share.

The options vest 25% on the grant date and the remaining portion vests in three equal annual installments beginning on the one-year anniversary of the grant date. The options become exercisable starting 11/17/2025 and expire on 11/17/2035, providing a long-term incentive tied to the company’s share price performance.